Medical Bulletin 21/February/2022

Published On 2022-02-22 09:46 GMT   |   Update On 2022-02-22 09:46 GMT

Here are Top medical stories for the dayChoice of anticoagulants to prevent Abnormal uterine bleeding Thrombosis UpdateWomen of childbearing potential have a high prevalence of venous thromboembolism due to high estrogen states, such as pregnancy and the use of estrogen-containing contraceptives. Abnormal uterine bleeding affects up to two-thirds of menstruating women on anticoagulation, and...

Login or Register to read the full article

Here are Top medical stories for the day

Choice of anticoagulants to prevent Abnormal uterine bleeding Thrombosis Update

Women of childbearing potential have a high prevalence of venous thromboembolism due to high estrogen states, such as pregnancy and the use of estrogen-containing contraceptives. Abnormal uterine bleeding affects up to two-thirds of menstruating women on anticoagulation, and can severely impair a woman's quality of life reports a study recently published in the Thrombosis Update journal.

 Low dose aspirin in pregnancy a high risk for preeclampsia Pregnancy Hypertension

Low Dose Aspirin triggers biosynthesis of endogenous anti-inflammatory molecules which may counteract inflammatory process of preeclampsia, and play some role in Low Dose Aspirin's mechanism of action in preeclampsia prevention in high-risk patients, according to a recent Study in Pregnancy Hypertension journal.


Colchicine cheap and low-risk medication to reduce MACE in patients undergoing PCI

A recent study showed that colchicine significantly reduces MACE risk in coronary artery disease (CAD) patients who underwent percutaneous coronary intervention (PCI). Colchicine reduced the risk of repeat vessel revascularization, stent thrombosis, and stroke. The study appears in the BMJ journal Open Heart.

PCI is the preferred coronary reperfusion strategy that induces endothelial trauma which may scale an inflammatory response. This may increase the likelihood of further major adverse cardiovascular events (MACE). Colchicine is a cheap and widely used anti-inflammatory that has shown promise in improving cardiovascular outcomes. Considering this, Kah Long Aw, Oxford University Hospitals NHS Trust, Oxford, UK, and colleagues aimed to perform a systematic review and meta-analysis to study the effects of colchicine in patients with symptomatic CAD who have undergone PCI.

For more details, check out the full story on the link below:

Colchicine Cheap And Low-Risk Medication To Reduce MACE In Patients Undergoing PCI: BMJ

 Eating prunes may help protect against bone loss in postmenopausal women

 It's already well known that prunes are good for your gut, but new Penn State research suggests they may be good for bone health, too.

In a research review, the researchers found that prunes can help prevent or delay bone loss in postmenopausal women, possibly due to their ability to reduce inflammation and oxidative stress, both of which contribute to bone loss.

For more information check out the full story on the link below:

Eating Prunes May Help Protect Against Bone Loss In Postmenopausal Women 


Depression strongly linked to lower urinary tract symptoms in men

The close link between lower urinary tract symptoms (LUTS) and depression suggests that there are common risk factors that cannot be assigned entirely to the prostate. This has direct ramifications for future research as well as the evaluation and treatment of people suffering from either illness, says an article published in the journal Neurourology and Urodynamics.

Men's LUTS and depression have a bidirectional relationship, according to new data from observational studies. Sean A. Martin and colleagues wanted to see if the presence of LUTS had an influence on depressive symptoms in adult men when compared to those who did not have LUTS, and vice versa.

For more information check out the full story on the link below:

Depression Strongly Linked To Lower Urinary Tract Symptoms In Men

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 04/ May/ 2024
Medical Bulletin 03/ May/ 2024